Welcome to our dedicated page for Docusign SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Docusign, Inc. (NASDAQ: DOCU), a software company focused on digital agreements, eSignature, and Intelligent Agreement Management (IAM). Through these filings, investors can review the company’s official disclosures on financial performance, risk factors, governance, and key business developments.
Annual reports on Form 10-K typically include detailed discussions of DocuSign’s business, including its IAM platform, eSignature and contract lifecycle management offerings, customer base, and the risks and opportunities associated with its operations. Quarterly reports on Form 10-Q provide interim financial statements, management’s discussion and analysis, and updates on metrics such as revenue, subscription trends, billings, and cash flows.
Current reports on Form 8-K disclose material events, such as quarterly financial results and certain corporate governance changes. For example, DocuSign has used Form 8-K to report financial results for specific quarters and to announce board appointments and leadership roles. These filings help investors track significant developments between regular reporting periods.
Other filings, such as proxy statements and any Form 4 insider transaction reports, can offer additional insight into executive and director compensation, equity awards, and share ownership, as well as governance practices. Together, these documents form the regulatory record of DOCU as a Nasdaq-listed issuer.
On Stock Titan, SEC filings for DOCU are updated from the EDGAR system, and AI-powered summaries can assist readers by highlighting key points from lengthy documents like 10-Ks and 10-Qs. This can help users quickly understand DocuSign’s reported results, non-GAAP metrics, and material events without reading every page of each filing.
Reporting person: Paula Hansen, Chief Revenue Officer at DocuSign, Inc. (DOCU). The filing shows an ESPP purchase and several sales under a Rule 10b5-1 plan. On 10/03/2025 Ms. Hansen acquired 245 shares through the 2018 Employee Stock Purchase Plan at an effective price of $59.27 per share. On 10/07/2025 she sold a total of 6,000 shares in three transactions at weighted prices in the $70.23–$72.80 range, reducing her beneficially owned shares from 64,968 to 58,968. The sales are reported as made pursuant to a Rule 10b5-1 plan and price ranges per tranche are disclosed in the remarks.
DOCUSIGN, INC. notice of a proposed sale under Rule 144 reports 6,000 common shares to be sold through Morgan Stanley Smith Barney LLC for an aggregate market value of $427,950. The filing lists the approximate date of sale as 10/07/2025 and shows 201,104,117 shares outstanding. The 6,000 shares were acquired in two tranches from the issuer as equity compensation: 3,000 performance shares on 06/10/2025 and 3,000 restricted stock on 08/10/2025. No other sales in the past three months are reported and the filer represents they have no undisclosed material nonpublic information.
DocuSign insider sales: Chief Financial Officer Blake Jeffrey sold a total of 6,500 shares of DOCU on 10/01/2025. The transactions were executed as two separate dispositions: 1,751 shares at prices ranging from $70.09 to $70.97 and 4,749 shares at prices ranging from $71.09 to $71.82. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan.
After these sales the reporting person beneficially owns 105,660 shares directly. The filing is a routine insider-sale disclosure and does not include any amendments, option exercises, or derivative transactions.
James P. Shaughnessy, Chief Legal Officer of DocuSign, Inc. (DOCU), reported two sales of common stock on 10/01/2025 executed under a Rule 10b5-1 plan. The filing shows a sale of 1,918 shares at prices ranging $70.05–$70.97 (noted as an aggregate price entry of $70.71) leaving 61,024 shares beneficially owned, and a separate sale of 5,582 shares at prices ranging $71.00–$71.75 (aggregate shown as $71.36) leaving 55,442 shares beneficially owned. The transactions total 7,500 shares sold. The Form 4 is signed by an attorney-in-fact and includes statements that full per-price sale breakdowns will be provided upon request.
DOCUSIGN, INC. (DOCU) Form 144 filing reports a proposed sale of 40,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $2,883,600 and an approximate sale date of 10/01/2025. The shares were acquired from the issuer on 12/15/2024 as RSUs & PSUs, and the filer reports no securities sold in the prior three months. The filer also certifies that, by signing the notice, they do not possess undisclosed material adverse information about the issuer.
DOCUSIGN, INC. (DOCU) submitted a Form 144 reporting a proposed sale of 6,500 restricted common shares through Morgan Stanley Smith Barney, with an aggregate market value of $462,848.10 and an approximate sale date of 10/01/2025. The shares were acquired as restricted stock on 06/10/2024 from the issuer and paid in full on that date. The filing also lists a prior sale by Blake J Grayson of 9,509 shares on 09/17/2025 for gross proceeds of $790,220.73. The filing identifies the broker and reports the issuer's outstanding shares as 201,104,117.
DOCUSIGN, INC. (DOCU) filed a Form 144 notifying the proposed sale of 7,500 common shares, with an aggregate market value of $533,977.50, through Morgan Stanley Smith Barney LLC on or about 10/01/2025. The filing lists total shares outstanding as 201,104,117, indicating the sale represents a very small fraction of outstanding stock. All 7,500 shares were acquired as restricted stock from the issuer on four dates in 2023 and 2024, and no other sales by the reporting person were reported in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
DocuSign Chief Financial Officer Blake Grayson sold a total of 9,509 shares of DocuSign, Inc. (ticker DOCU) on 09/17/2025 under a pre-established Rule 10b5-1 trading plan. The sales consisted of 5,658 shares at prices ranging from $82.22 to $83.18 and 3,851 shares at prices ranging from $83.20 to $83.65. Following the transactions the reporting person beneficially owned 116,011 shares after the first sale and 112,160 shares after the second sale, reported as direct ownership. The Form 4 was signed by an attorney-in-fact.
Robert Chatwani, an officer (President General Mgr, Growth) of DocuSign, Inc. (DOCU), reported two open-market sales of Common Stock on 09/17/2025 executed under a Rule 10b5-1 plan. The Form 4 shows a sale of 8,215 shares at prices ranging from $82.20 to $83.18, after which the report lists 76,764 shares beneficially owned. A second sale on the same date of 5,602 shares occurred at prices ranging from $83.20 to $83.65, after which the report lists 71,162 shares beneficially owned. The filing was signed by an attorney-in-fact, and the Reporting Person will provide detailed per-price share counts on request.
James A. Beer, a director of DocuSign, reported a sale of 450 shares of the company's common stock at $81.28 per share. After the sale, he is reported to beneficially own 14,199 shares directly and 5,543 shares indirectly through a trust, showing he remains a meaningful stakeholder. The filing notes the sale was effected under a Rule 10b5-1 trading plan, indicating the transaction followed a pre-established arrangement rather than ad hoc trading.